Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (2018 - 2025)

AdaptHealth has reported Shares Outstanding over the past 8 years, most recently at $135.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $135.5 million for Q4 2025, up 0.63% from a year ago — trailing twelve months through Dec 2025 was $135.5 million (up 0.63% YoY), and the annual figure for FY2025 was $135.5 million, up 0.63%.
  • Shares Outstanding for Q4 2025 was $135.5 million at AdaptHealth, roughly flat from $135.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AHCO hit a ceiling of $135.5 million in Q4 2025 and a floor of $129.4 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $134.4 million (2022), compared with a mean of $127.1 million.
  • Biggest five-year swings in Shares Outstanding: soared 324.14% in 2021 and later dropped 1.34% in 2023.
  • AdaptHealth's Shares Outstanding stood at $133.8 million in 2021, then grew by 0.44% to $134.4 million in 2022, then fell by 1.34% to $132.6 million in 2023, then rose by 1.48% to $134.6 million in 2024, then increased by 0.63% to $135.5 million in 2025.
  • The last three reported values for Shares Outstanding were $135.5 million (Q4 2025), $135.4 million (Q3 2025), and $135.2 million (Q2 2025) per Business Quant data.